Delivery Order SPE2DB20D3101-SPE2DB25FRHT3
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $40,155.43 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside transaction executed on September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with extensive experience...
- The Defense Logistics Agency awarded a $127,949.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors, with a completion date of September 19, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $38,911.60 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This firm fixed price, non-set-aside contract will be completed by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $12,467 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a $16,496.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of June 18, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $18,136.65 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 22, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $38,306.42 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations for federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,588.83 for SKYRIZI 150 mg/mL pen injectors on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price contract, which received no set-aside designation, represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $59,150 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 28, 2025. This non-set-aside competitive award was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order under a larger indefinite delivery contract vehicle, this award represents a tactical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at approximately $121,000 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML pen injectors. The contract, issued on September 22, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price transaction with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRHT3Delivery Order
The Defense Logistics Agency awarded a $54,511.48 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This competitive award, issued without set-aside designation, utilizes a firm fixed-price delivery order structure under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The delivery order represents a routine pharmaceutical supply fulfillment under AmerisourceBergen's $999.999 billion IDC with DLA Troop Support Medical (contract SPE2DX), which operates through December 2026 and provides comprehensive global pharmaceutical support for military healthcare programs. SKYRIZI, a specialty pharmaceutical product, aligns with AmerisourceBergen's established portfolio of brand-name medications supplied through the DLA Medical Supply Chain to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The rapid completion timeline reflects the time-sensitive nature of pharmaceutical procurement for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.5k | 4/24/25 |